Belite Bio (BLTE) Other Non Operating Income (2024 - 2025)
Belite Bio (BLTE) posted quarterly Other Non Operating Income of -$417000.0 for Q4 2025, down 406.62% year-over-year from $136000.0 in Q4 2024, and down 406.62% quarter-over-quarter from $136000.0 in Q4 2024.
Powered by 
Analysis
Belite Bio (BLTE) Other Non Operating Income (2024 - 2025) Analysis & Trends
Belite Bio's Other Non Operating Income history runs 2 years deep, the most recent figure standing at -$417000.0 for Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Belite Bio | 6.28 Bn | 6.28 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -417,000.00 |
| Dec 31, 2024 | 136,000.00 |